telmisartan has been researched along with Albuminuria in 63 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.59) | 18.2507 |
| 2000's | 22 (34.92) | 29.6817 |
| 2010's | 37 (58.73) | 24.3611 |
| 2020's | 3 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, W; Lei, C; Wei, L; Zhan, X | 1 |
| Curovic, VR; Hansen, TW; Heerspink, HJL; Jongs, N; Kooy, A; Kroonen, MYAM; Laverman, GD; Persson, F; Rossing, P; Sen, T; Zobel, EH | 1 |
| Gill, A; Jarolimek, W; Pollock, C; Saad, S; Schilter, H; Stangenberg, S; Wong, MG; Wong, MY; Zaky, A | 1 |
| Gill, A; Pollock, CA; Saad, S; Schilter, HC; Stangenberg, S; Wong, MG; Zaky, A | 1 |
| Chernatska, O; Demikhova, N | 1 |
| Sharma, K; Sweiss, N | 1 |
| Daikuhara, H; Fukunaga, K; Ohshima, T | 1 |
| Kaul, U; Mansoor, A; Sabbah, ZA | 1 |
| Gangadharan Komala, M; Gross, S; Huang, C; Mather, A; Mudaliar, H; Panchapakesan, U; Pegg, K; Pollock, CA; Shen, S | 1 |
| Abebe, KZ; Braun, WE; Brosnahan, G; Chapman, AB; Czarnecki, PG; Flessner, MF; Grantham, JJ; Harris, PC; Hogan, MC; Miskulin, DC; Moore, CG; Perrone, RD; Rahbari-Oskoui, FF; Schrier, RW; Steinman, TI; Torres, VE; Winklhofer, FT | 1 |
| Asanuma, E; Asanuma, K; Asao, R; Jeong, KH; Kodama, F; Lydia, A; Takagi, M; Tomino, Y | 1 |
| Jinnouchi, H; Kataoka, K; Kim-Mitsuyama, S; Matsui, K; Node, K; Ogawa, H; Sekigami, T; Soejima, H; Yamamoto, E; Yamamuro, M; Yasuda, O | 1 |
| Alter, M; Ando, R; Antonenko, V; Chaykovska, L; Hasan, AA; Hocher, B; Klein, T; Okuda, S; Rahnenführer, J; Reichetzeder, C; Sharkovska, Y; Tammen, H; Tsuprykov, O; Ueda, S; von Websky, K; Yamagishi, SI | 1 |
| Bi, G; Cao, K; Fang, D; He, Y; Li, Z; Song, X; Wang, F; Wei, Y; Wu, J; Yang, J; Zhang, Z | 1 |
| Galle, J | 1 |
| Babazono, T; Haneda, M; Ito, S; Iwamoto, Y; Katayama, S; Kawamori, R; Makino, H; Moriya, T; Takeuchi, M | 2 |
| Hosomi, N; Imanishi, M; Ito, S; Kiyomoto, H; Kobori, H; Konishi, Y; Meda, I; Mori, T; Morikawa, T; Nagai, Y; Nakagawa, T; Nishiyama, A; Okada, N; Okumura, M | 1 |
| Baliga, V; Sharma, A | 1 |
| Hamamoto, Y; Honjo, S; Ikeda, H; Koshiyama, H; Nabe, K; Wada, Y | 1 |
| Avezum, A; Cardona-Munoz, E; Dagenais, GR; Diaz, R; Dyal, L; Fodor, G; Maillon, JM; Mann, JF; McQueen, MJ; Pogue, J; Probstfield, JL; Rydén, L; Schmieder, RE; Schumacher, H; Teo, KK; Wang, X; Yu, CM; Yusuf, S | 1 |
| Mazerska, M; Myśliwiec, M | 1 |
| Ekinci, EI; Finch, S; Houlihan, CA; Jerums, G; Johnson, C; Macisaac, RJ; O'Callaghan, C; Panagiotopoulos, S; Thomas, D; Thomas, G | 1 |
| Bakris, GL; Kalaitzidis, R | 1 |
| Ito, S | 1 |
| de Boer, IH; Pichler, RH | 1 |
| Ichihara, A; Itoh, H; Kinouchi, K; Kurauchi-Mito, A; Murohashi-Bokuda, K; Sakoda, M | 1 |
| Anantharaman, R; Bhadada, SK; Bhansali, A; Dutta, P; Jayaprakash, P; Kohli, HS; Upreti, V; Walia, R | 1 |
| Chen, C; Ding, G; Hu, F; Liang, W; Ren, Z; Shi, J; Singhal, PC; van Goor, H | 1 |
| Clase, CM; Gao, P; Grosshennig, A; Mann, JF; McQueen, M; Teo, KK; Tobe, SW; Wang, X; Yusuf, S | 1 |
| Jain, A; Rao, RP; Srinivasan, B | 1 |
| Makino, H; Ogawa, D | 1 |
| Fujiwara, N; Kawagoe, Y; Koide, H; Nakamura, T; Sato, E; Ueda, Y; Yamada, S | 1 |
| Fujishima, H; Fujita, H; Komatsu, K; Morii, T; Narita, T; Sakamoto, T; Takahashi, T; Yamada, Y | 1 |
| Jennings, G; Liu, GL; Mancia, G; Redon, J; Ryden, L; Schmieder, R; Schumacher, H; Sleight, P; Teo, K; Verdecchia, P; Yusoff, K; Yusuf, S | 1 |
| Anabitarte-Prieto, A; Companioni, O; García-Bello, MA; Nóvoa-Mogollón, FJ; Plaza-Toledano, C; Rodríguez-Esparragón, F; Rodríguez-Pérez, JC; Suárez-Ortega, S | 1 |
| Akhrass, PR; McFarlane, SI | 1 |
| Anantharaman, R; Bhadada, SK; Bhansali, A; Jayaprakash, P; Kohli, HS; Shanmugasundar, G; Walia, R | 1 |
| Balakumar, P; Bishnoi, HK; Mahadevan, N | 1 |
| Boiocchi, C; Bozzini, S; Buzzi, MP; Choi, J; D'Angelo, A; Esposito, C; Falcone, C; Mancia, G; Ochan Kilama, M; Schirinzi, S; Torreggiani, M | 1 |
| Goto, SN; Iwata, K; Takagi, H; Umemoto, T; Yamamoto, H | 1 |
| Abe, M; Fujii, Y; Ito, M; Maruyama, N; Okada, K; Soma, M; Suzuki, H; Yoshida, Y | 1 |
| Kikuchi, T; Kimura, H; Mitsuhashi, T; Otsuka, K; Tsuchida, Y; Watanabe, Y | 1 |
| Di Iorio, A; Falasca, K; Mancino, P; Ucciferri, C; Vecchiet, J | 1 |
| Dohi, Y; Kimura, G; Kojima, M; Ohashi, M | 1 |
| Barzilay, JI; Clase, CM; Gao, P; Mann, JF; Mente, A; Sleight, P; Teo, KK; Yusuf, S | 1 |
| Chatzikyrkou, C; Menne, J | 1 |
| Bednarski, R; Donderski, R; Heleniak, Z; Lizakowski, S; Manitius, J; Przybylska, M; Renke, M; Rutkowski, B; Rutkowski, P; Sulikowska, B; Tylicki, L | 1 |
| Dhakad, PK; Joshi, M; Joshi, S; Kanawat, DS; Kurmi, MK; Mishra, A; Raikwar, SK; Sharma, AK; Sharma, P; Srinivasan, BP; Srivastava, V | 1 |
| Chaves, FJ; Luque-Otero, M; Martell, N; Redon, J | 1 |
| Luño, J | 1 |
| Altuntas, Y; Aydin, L; Kürklü, A; Sengul, AM | 1 |
| Baliga, V; Desai, A; Gawde, A; Hariharan, RS; Kulkarni, BN; Kulkarni, RB; Naikwadi, A | 1 |
| de Zeeuw, D; Köster, J; Manolis, AJ; Navis, G; Reid, JL; Vogt, L | 1 |
| Ak, ND; Fujisaka, S; Hachiya, H; Iwata, M; Kobayashi, M; Murakami, S; Sasaoka, T; Satoh, A; Senda, S; Takano, A; Takata, M; Temaru, R; Urakaze, M; Usui, I; Yamazaki, K; Yamazaki, Y | 1 |
| Derosa, G; Destro, M; Fogari, E; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Rinaldi, A; Zoppi, A | 1 |
| Hoshide, S; Ishikawa, J; Ishikawa, S; Kanemaru, Y; Kario, K; Noguchi, C; Shimada, K; Tada, M; Takanori, H; Tukui, D; Yano, A; Yano, Y | 1 |
| Chachin, M; Hayashi, N; Hayashi, T; Horie, Y; Konomi, A; Matsumaru, T; Ohmura, T; Seidler, R; Sumida, T; Tsunenari, I | 1 |
| Bakris, G; Burgess, E; Davidai, G; Koval, S; Weir, M | 1 |
| Amann, K; Bohlender, J; Drab, M; Ganten, D; Wagner, J; Wienen, W | 1 |
| Audeval-Gerard, C; Champeroux, P; Richard, S; Wienen, W | 1 |
7 review(s) available for telmisartan and Albuminuria
| Article | Year |
|---|---|
Adiponectin effects on the kidney.
Topics: Adiponectin; Albuminuria; Amlodipine; AMP-Activated Protein Kinases; Animals; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Progression; Humans; Kidney; Kidney Diseases; Mice; Obesity; Oxidative Stress; Perindopril; Renal Insufficiency, Chronic; Telmisartan | 2014 |
Reduction of proteinuria with angiotensin receptor blockers.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Biomarkers; Cardiovascular Diseases; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Telmisartan; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2008 |
Dual renin-angiotensin-aldosterone system blockade for diabetic kidney disease.
Topics: Albuminuria; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Benzimidazoles; Benzoates; Diabetic Nephropathies; Humans; Hyperkalemia; Models, Biological; Ramipril; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Telmisartan | 2010 |
Telmisartan and cardioprotection.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Cardiotonic Agents; Cardiovascular Diseases; Diabetes Mellitus; Humans; Hypertension; Risk; Telmisartan | 2011 |
Telmisartan in the management of diabetic nephropathy: a contemporary view.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Diabetes Mellitus; Diabetic Nephropathies; Disease Progression; Female; Humans; Hypertension; Kidney Diseases; Male; Telmisartan; Treatment Outcome | 2012 |
Effects of telmisartan on proteinuria or albuminuria: a meta-analysis of randomized trials.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Humans; Proteinuria; Randomized Controlled Trials as Topic; Telmisartan; Treatment Outcome | 2013 |
[Renin-angiotensin system in diabetic nephropathy].
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Drug Therapy, Combination; Homeostasis; Humans; Lisinopril; Losartan; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors; Telmisartan | 2005 |
33 trial(s) available for telmisartan and Albuminuria
| Article | Year |
|---|---|
Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover Trial.
Topics: Adult; Albuminuria; Creatinine; Cross-Over Studies; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glomerular Filtration Rate; Humans; Linagliptin; Rotation; Telmisartan | 2023 |
IMPROVEMENT OF TREATMENT IN PERSONS WITH ARTERIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUS.
Topics: Albuminuria; Antihypertensive Agents; Blood Pressure; Comorbidity; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Endothelin-1; Glycated Hemoglobin; Humans; Hypertension; Lisinopril; Middle Aged; Renin-Angiotensin System; Telmisartan; Treatment Outcome | 2018 |
Difference in the effects of switching from candesartan to olmesartan or telmisartan to olmesartan in hypertensive patients with type 2 diabetes: the COTO study.
Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Telmisartan; Tetrazoles | 2014 |
Angiotensin blockade in late autosomal dominant polycystic kidney disease.
Topics: Adolescent; Adult; Albuminuria; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Polycystic Kidney, Autosomal Dominant; Renal Insufficiency, Chronic; Telmisartan; Young Adult | 2014 |
A trial of telmisartan prevention of cardiovascular diseases (ATTEMPT-CVD): Biomarker study.
Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Biomarkers; Blood Pressure; Cardiovascular Diseases; Creatinine; Female; Humans; Hypertension; Incidence; Japan; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Risk Factors; Telmisartan; Time Factors; Treatment Outcome | 2016 |
Microalbuminuria reduction with telmisartan in normotensive and hypertensive Japanese patients with type 2 diabetes: a post-hoc analysis of The Incipient to Overt: Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATI
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Female; Humans; Hypertension, Renal; Japan; Male; Middle Aged; Telmisartan; Treatment Outcome | 2008 |
Evaluation of fixed dose combination (FDC) of telmisartan+ramipril usage in patients with micro-albuminuria and persistent hypertension: A TRIUMPH study.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Biomarkers; Female; Humans; Hypertension; Male; Middle Aged; Product Surveillance, Postmarketing; Prospective Studies; Ramipril; Telmisartan | 2008 |
Olmesartan reduced microalbuminuria in Japanese subjects with type 2 diabetes.
Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Asian People; Benzimidazoles; Benzoates; Biphenyl Compounds; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hypertension; Imidazoles; Losartan; Male; Middle Aged; Telmisartan; Tetrazoles; Valine; Valsartan | 2009 |
Effect of telmisartan on renal outcomes: a randomized trial.
Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Coronary Artery Disease; Creatinine; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Risk Factors; Telmisartan | 2009 |
Telmisartan lowers albuminuria in type 2 diabetic patients treated with angiotensin enzyme inhibitors.
Topics: Aged; Albuminuria; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Pilot Projects; Telmisartan | 2009 |
Effects of salt supplementation on the albuminuric response to telmisartan with or without hydrochlorothiazide therapy in hypertensive patients with type 2 diabetes are modulated by habitual dietary salt intake.
Topics: Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 2; Dietary Supplements; Female; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Sodium Chloride; Sodium, Dietary; Telmisartan | 2009 |
Effects of telmisartan on arterial stiffness assessed by the cardio-ankle vascular index in hypertensive patients.
Topics: Adult; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Ankle; Arteries; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Determination; Calcium Channel Blockers; Female; Humans; Hypertension, Renal; Male; Middle Aged; Models, Cardiovascular; Telmisartan; Treatment Outcome | 2010 |
Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies.
Topics: Aged; Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Creatinine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Heart Failure; Heart Rate; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Ramipril; Stroke; Telmisartan; Treatment Outcome | 2011 |
[INNOVATION study].
Topics: Adult; Aged; Albuminuria; Angiotensin Receptor Antagonists; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Humans; Male; Middle Aged; Telmisartan | 2010 |
Changes in urinary albumin excretion, inflammatory and oxidative stress markers in ADPKD patients with hypertension.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Biomarkers; Creatinine; Deoxyguanosine; Enalapril; Female; HMGB1 Protein; Humans; Hypertension; Inflammation; Interleukin-6; Male; Middle Aged; Oxidative Stress; Polycystic Kidney, Autosomal Dominant; Telmisartan | 2012 |
Reduction of circulating superoxide dismutase activity in type 2 diabetic patients with microalbuminuria and its modulation by telmisartan therapy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Antioxidants; Benzimidazoles; Benzoates; Cross-Over Studies; Deoxyguanosine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Japan; Losartan; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Superoxide Dismutase; Telmisartan; Tyrosine | 2011 |
Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET).
Topics: Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Therapy, Combination; Guidelines as Topic; Humans; Incidence; Kidney Diseases; Middle Aged; Ramipril; Risk; Stroke; Telmisartan | 2011 |
Anti-albuminuric effects of the angiotensin AT1 receptor blocker telmisartan in hypertensive patients.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Creatinine; Diabetic Nephropathies; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Hypertension, Renal; Male; Middle Aged; Prospective Studies; Sulfonamides; Telmisartan; Torsemide; Treatment Outcome | 2011 |
Microalbuminuria and sRAGE in high-risk hypertensive patients treated with nifedipine/telmisartan combination treatment: a substudy of TALENT.
Topics: Adolescent; Adult; Aged; Albuminuria; Antihypertensive Agents; Benzimidazoles; Benzoates; Drug Combinations; Female; Glycation End Products, Advanced; Humans; Hypertension; Male; Middle Aged; Nifedipine; Telmisartan; Young Adult | 2012 |
Additive renoprotective effects of aliskiren on angiotensin receptor blocker and calcium channel blocker treatments for type 2 diabetic patients with albuminuria.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Aged; Albuminuria; Aldosterone; Amides; Amlodipine; Angiotensin II Type 2 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Deoxyguanosine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Fatty Acid-Binding Proteins; Female; Fumarates; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Male; Middle Aged; Renin; Telmisartan; Young Adult | 2012 |
Administration of angiotensin receptor II blockade improves vascular function, urinary albumin excretion, and left ventricular hypertrophy in low-risk essential hypertensive patients receiving antihypertensive treatment with calcium channel blockers.
Topics: Aged; Aged, 80 and over; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Incidence; Male; Middle Aged; Risk Factors; Sodium Chloride; Telmisartan; Treatment Outcome | 2013 |
Titration of telmisartan, but not addition of amlodipine, reduces urine albumin in diabetic patients treated with telmisartan-diuretic.
Topics: Adult; Aged; Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Female; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Telmisartan; Treatment Outcome | 2013 |
Albuminuria and rapid loss of GFR and risk of new hip and pelvic fractures.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Fractures, Bone; Glomerular Filtration Rate; Hip Fractures; Humans; Pelvic Bones; Prospective Studies; Ramipril; Risk Factors; Telmisartan; Time Factors | 2013 |
The enhanced renin-angiotensin-aldosteron system pharmacological blockade--which is the best?.
Topics: Adult; Albuminuria; Amides; Angiotensin Receptor Antagonists; Benzimidazoles; Benzoates; Comorbidity; Cross-Over Studies; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Eplerenone; Female; Fumarates; Humans; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Prospective Studies; Proteinuria; Renal Insufficiency, Chronic; Renin; Renin-Angiotensin System; Severity of Illness Index; Spironolactone; Telmisartan; Treatment Outcome | 2012 |
Renin-angiotensin system gene polymorphisms: relationship with blood pressure and microalbuminuria in telmisartan-treated hypertensive patients.
Topics: Aged; Albuminuria; Benzimidazoles; Benzoates; Blood Pressure; Female; Humans; Hypertension; Male; Middle Aged; Polymorphism, Genetic; Prospective Studies; Renin-Angiotensin System; Telmisartan | 2005 |
Beneficial effect of lisinopril plus telmisartan in patients with type 2 diabetes, microalbuminuria and hypertension.
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Creatinine; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Female; Humans; Hypertension; Lisinopril; Male; Middle Aged; Prospective Studies; Telmisartan | 2006 |
A pilot study for evaluation of the efficacy and safety of telmisartan in reducing microalbuminuria in hypertensive patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Albuminuria; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hypertension; Infant; Male; Middle Aged; Pilot Projects; Prospective Studies; Safety; Single-Blind Method; Telmisartan | 2005 |
The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Back Pain; Benzimidazoles; Benzoates; Blood Pressure; Bronchitis; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Telmisartan; Treatment Outcome | 2005 |
Telmisartan reduced blood pressure and HOMA-IR with increasing plasma leptin level in hypertensive and type 2 diabetic patients.
Topics: Adiponectin; Adult; Aged; Aged, 80 and over; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Body Mass Index; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diet, Diabetic; Female; Humans; Hypertension; Hypoglycemic Agents; Leptin; Lipids; Male; Middle Aged; Telmisartan | 2007 |
Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria.
Topics: Adult; Aged; Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Telmisartan | 2007 |
Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes.
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Diabetic Nephropathies; Double-Blind Method; Humans; Middle Aged; Placebos; Telmisartan | 2007 |
The differential effects of angiotensin II type 1 receptor blockers on microalbuminuria in relation to low-grade inflammation in metabolic hypertensive patients.
Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; C-Reactive Protein; Female; Humans; Hypertension; Inflammation; Male; Metabolic Syndrome; PPAR gamma; Telmisartan; Treatment Outcome | 2007 |
Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy.
Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Creatinine; Diabetic Nephropathies; Double-Blind Method; Female; Half-Life; Humans; Hypertension; Losartan; Male; Middle Aged; Proteinuria; Telmisartan | 2008 |
23 other study(ies) available for telmisartan and Albuminuria
| Article | Year |
|---|---|
Telmisartan Mitigates High-Glucose-Induced Injury in Renal Glomerular Endothelial Cells (rGECs) and Albuminuria in Diabetes Mice.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Membrane Permeability; Diabetic Nephropathies; Endothelial Cells; Humans; Kidney Glomerulus; Male; Membrane Potential, Mitochondrial; Mice, Inbred C57BL; Mitochondria; Occludin; Oxidative Stress; Receptor, Angiotensin, Type 1; Telmisartan | 2021 |
Semicarbazide-sensitive amine oxidase inhibition ameliorates albuminuria and glomerulosclerosis but does not improve tubulointerstitial fibrosis in diabetic nephropathy.
Topics: Albuminuria; Allylamine; Amine Oxidase (Copper-Containing); Animals; Benzamides; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Inhibitors; Fibronectins; Fibrosis; Kidney Glomerulus; Kidney Tubules; Leukocyte Common Antigens; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Renal Insufficiency, Chronic; Telmisartan | 2020 |
Lysyl oxidase-like 2 inhibition ameliorates glomerulosclerosis and albuminuria in diabetic nephropathy.
Topics: Albuminuria; Amino Acid Oxidoreductases; Animals; Collagen; Diabetic Nephropathies; Enzyme Inhibitors; Fibronectins; Kidney; Male; Mice; Mice, Inbred C57BL; Telmisartan | 2018 |
Angiotensin receptor blockers - advantages of the new sartans.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Atherosclerosis; Benzimidazoles; Benzoates; Cardiovascular Diseases; Humans; Hypertension; Imidazoles; Olmesartan Medoxomil; Oxadiazoles; Telmisartan; Tetrazoles; Treatment Outcome | 2013 |
Inhibition of kidney proximal tubular glucose reabsorption does not prevent against diabetic nephropathy in type 1 diabetic eNOS knockout mice.
Topics: Albuminuria; Animals; Benzhydryl Compounds; Benzimidazoles; Benzoates; Blood Glucose; Chemokine CCL2; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibronectins; Glucose Transporter Type 1; Glucosides; Hypoglycemic Agents; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type III; RNA, Messenger; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin; Telmisartan; Toll-Like Receptor 2; Transforming Growth Factor beta1 | 2014 |
Combination therapy with telmisartan and oxacalcitriol suppresses the progression of murine adriamycin nephropathy.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Animals; Antibiotics, Antineoplastic; Apoptosis; Benzimidazoles; Benzoates; Calcitriol; Doxorubicin; Drug Therapy, Combination; Female; Glomerulosclerosis, Focal Segmental; Intracellular Signaling Peptides and Proteins; Kidney Diseases; Membrane Proteins; Mice; Mice, Inbred BALB C; Podocytes; Telmisartan | 2015 |
The dipeptidyl peptidase inhibitor linagliptin and the angiotensin II receptor blocker telmisartan show renal benefit by different pathways in rats with 5/6 nephrectomy.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biomarkers; Blood Pressure; Chromatography, Liquid; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Fibrosis; Kidney; Linagliptin; Male; Mass Spectrometry; Nephrectomy; Rats, Inbred F344; Rats, Sprague-Dawley; Rats, Transgenic; Renal Insufficiency, Chronic; Renin-Angiotensin System; Signal Transduction; Telmisartan; Time Factors | 2016 |
Adjunctive therapy with statins reduces residual albuminuria/proteinuria and provides further renoprotection by downregulating the angiotensin II-AT1 pathway in hypertensive nephropathy.
Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Down-Regulation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Renal; Kidney; Male; Nephritis; NF-kappa B; Proteinuria; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction; Telmisartan; Transforming Growth Factor beta | 2017 |
Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria.
Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Collagen; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Hypertension, Renal; Kidney Cortex; Male; Podocytes; Rats; Rats, Inbred OLETF; RNA, Messenger; Telmisartan | 2008 |
Telmisartan did not prevent renal disease in patients without proteinuria.
Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Coronary Artery Disease; Creatinine; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Risk Factors; Telmisartan | 2009 |
Effects of angiotensin II receptor blockers on diabetic nephropathy.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Diabetic Neuropathies; Disease Progression; Humans; Kaplan-Meier Estimate; Kidney; Proteinuria; Telmisartan | 2009 |
Usefulness of RAS inhibition depends on baseline albuminuria.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Humans; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Telmisartan | 2010 |
Anti-albuminuric efficacy of a combination of angiotensin converting enzyme inhibitor & angiotensin receptor blocker in type 1 DM with nephropathy.
Topics: Albumins; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Combinations; Female; Humans; Male; Potassium; Ramipril; Statistics, Nonparametric; Telmisartan | 2010 |
Disparate effects of eplerenone, amlodipine and telmisartan on podocyte injury in aldosterone-infused rats.
Topics: Albuminuria; Aldosterone; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Benzimidazoles; Benzoates; Blotting, Western; Calcium Channel Blockers; Eplerenone; Immunoenzyme Techniques; Kidney Glomerulus; Male; Membrane Proteins; Mineralocorticoid Receptor Antagonists; Podocytes; Proteinuria; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spironolactone; Telmisartan | 2011 |
Dual therapy versus monotherapy of trandolapril and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Therapy, Combination; Fasting; Female; Fibronectins; Indoles; Male; Rats; Telmisartan; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2011 |
A pilot study on the effect of telmisartan & ramipril on 24 h blood pressure profile & dipping pattern in type 1 diabetes patients with nephropathy.
Topics: Adult; Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pilot Projects; Ramipril; Telmisartan | 2011 |
Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan.
Topics: Adult; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Antiretroviral Therapy, Highly Active; Benzimidazoles; Benzoates; Biomarkers; Blood Pressure; Endothelium, Vascular; Glomerular Filtration Rate; HIV Infections; Humans; Hypertension; Insulin Resistance; Italy; Kidney; Male; Middle Aged; Telmisartan; Time Factors; Treatment Outcome | 2012 |
Targeting albuminuria in arterial hypertension and diabetes: how is it best achieved and what is its clinical relevance?
Topics: Albuminuria; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Female; Humans; Hypertension; Male; Telmisartan | 2013 |
Dual therapy of vildagliptin and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats.
Topics: Adamantane; Albuminuria; Animals; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Blood Urea Nitrogen; Body Weight; Creatinine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diastole; Drug Therapy, Combination; Fasting; Hypoglycemic Agents; Male; Nitriles; Pyrrolidines; Rats, Wistar; Systole; Telmisartan; Vildagliptin | 2014 |
[In the DETAIL. Kidney protection in manifestations of microalbuminuria].
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Enalapril; Glomerular Filtration Rate; Humans; Kidney; Prospective Studies; Randomized Controlled Trials as Topic; Telmisartan; Time Factors | 2006 |
Renoprotective effects of telmisartan on renal injury in obese Zucker rats.
Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Kidney; Male; Proteinuria; Rats; Rats, Zucker; Telmisartan; Triglycerides; Urine | 2012 |
Effects of AT1 receptor blockade on blood pressure and the renin-angiotensin system in spontaneously hypertensive rats of the stroke prone strain.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Captopril; Cerebrovascular Disorders; Gene Expression; Hypertension; Kidney; Losartan; Male; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin; Renin-Angiotensin System; RNA, Messenger; Telmisartan | 1998 |
Comparative antihypertensive and renoprotective effects of telmisartan and lisinopril after long-term treatment in hypertensive diabetic rats.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Hyperglycemia; Hypertension; Kidney; Kidney Glomerulus; Lisinopril; Male; Organ Size; Proteinuria; Rats; Rats, Inbred SHR; Reference Values; Telmisartan | 2001 |